Checked.be
Active
BE 0717.749.223Private limited company
VW MEDIC
Rue Napoléon Anrys(GER) 2 ·6280 Gerpinnes, Belgium· 7 yrs active
Sector: Specialist medical practice
(86220)
Conclusion
VW MEDIC has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €554k and a net result of €319k. Equity is growing by ~14.4% per year across the filed fiscal years. Its solvency ranks better than 43% of 16012 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Based on the State Gazette, CBE and 5 annual accounts.
Key figures
| Equity | €554k |
| Net result | €319k |
| Staff (FTE) | 1 |
| Better than sector | 43% |
Financial profile
95
/ 100
Exceptional profile, strong across almost every axis.
All 5 axes are computed from data Checked has read.
Health
100
Profitability
100
Solvency
97
Growth
78
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2019, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
100
/ 100
Excellent
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
€55k
estimate, not credit advice
Score history
93
2021
73
2022
94
2023
100
2024
100
2025
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 2.16 (≥ 1.5)
+10
Quick ratio
Quick ratio 2.16 (≥ 1.0)
+5
Leverage
Debt/equity 0.83 (< 1.0)
+10
Profitability
ROE 58% (≥ 10%)
+10
Interest coverage
Interest coverage 121.1× (≥ 3×)
+8
Profit trend
Net profit up YoY
+5
Equity growth
Equity growing YoY
+3
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.
Financial overview
Annual accounts filed on 11-05-2026 with the NBB · fiscal year 2025 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
growing
Equity: growth of ~14.4%/year over 5 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Sector comparison
Fiscal year 2025 · NACE 86, Human health activities · compared within the same schema type (micro schema)
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 54.6% | 63.4% | |
| Net result | €319k | €62k | |
| Equity | €554k | €132k | |
| Gross operating margin | €449k | €116k | |
| Staff costs | €8k | €29k |
€440k
+9.7%
21-25
€319k
+11.2%
21-25
€340k
+10.7%
21-25
€1.01M
+12.2%
21-25
€554k
+11.8%
21-25
€318k
+80.1%
21-25
1
0.0%
21-25
€8k
-29.9%
21-25
€101k
+12.1%
21-25
€260k
+47.5%
21-25
€460k
+12.6%
21-25
€274k
+34.9%
21-25
€184k
-9.5%
21-25
2.16
+15.6%
21-25
2.16
+15.6%
21-25
54.6%
-0.3%
21-25
0.83
+0.7%
21-25
57.5%
-0.5%
21-25
31.4%
-0.9%
21-25
121.10
+19.6%
21-25
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €440k | €401k | €412k | €350k | €285k |
| Net profit | €319k | €287k | €279k | €228k | €213k |
| Cash flow | €340k | €307k | €302k | €246k | €222k |
| Staff costs | €8k | €11k | €10k | €11k | €8k |
| Income taxes | €101k | €90k | €105k | €101k | €60k |
| Dividends | €260k | €176k | €147k | €500k | €20k |
| Total assets | €1.01M | €904k | €806k | €1.06M | €696k |
| Equity | €554k | €496k | €385k | €255k | €527k |
| Debt | €460k | €409k | €421k | €803k | €169k |
| of which ≤ 1y | €274k | €203k | €196k | €556k | €38k |
| of which > 1y | €184k | €204k | €223k | €245k | €130k |
| Working capital | €318k | €177k | €191k | €74k | €479k |
| Employees (FTE) | 1.0 | 1.0 | 1.0 | 1.0 | 0.8 |
Ratios (computed)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Current ratio | 2.16 | 1.87 | 1.98 | 1.13 | 13.61 |
| Quick ratio | 2.16 | 1.87 | 1.98 | 1.13 | 13.61 |
| Working capital ratio | 31.4% | 19.5% | 23.7% | 7.0% | 68.9% |
| Solvency | 54.6% | 54.8% | 47.8% | 24.1% | 75.7% |
| Debt / equity | 0.83 | 0.82 | 1.09 | 3.15 | 0.32 |
| Long-term debt ratio | 0.33 | 0.41 | 0.58 | 0.96 | 0.25 |
| Interest coverage | 121.10 | 101.22 | 95.76 | 100.34 | 104.79 |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | 31.4% | 31.7% | 34.6% | 21.6% | 30.6% |
| ROE | 57.5% | 57.8% | 72.4% | 89.5% | 40.4% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Balance-sheet composition 2025
Full annual accounts (25 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €1.01M | €904k | €806k | €1.06M | €696k |
| Fixed assets | 21/28 | €422k | €525k | €419k | €428k | €179k |
| Tangible fixed assets | 22/27 | €422k | €425k | €419k | €428k | €179k |
| Financial fixed assets | 28 | €0 | €100k | - | - | €146 |
| Current assets | 29/58 | €592k | €380k | €387k | €630k | €517k |
| Amounts receivable within one year | 40/41 | €25k | €2k | €443 | €488 | €6k |
| Investments | 50/53 | €100k | - | - | - | - |
| Cash & bank | 54/58 | €265k | €208k | €204k | €460k | €380k |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €1.01M | €904k | €806k | €1.06M | €696k |
| Equity | 10/15 | €554k | €496k | €385k | €255k | €527k |
| Contributions / capital | 10/11 | €19k | €19k | €19k | €19k | €19k |
| Reserves | 13 | €367k | €367k | €367k | €230k | €2k |
| Accumulated profits (losses) | 14 | €169k | €110k | - | €6k | €506k |
| Amounts payable | 17/49 | €460k | €409k | €421k | €803k | €169k |
| Amounts payable after one year | 17 | €184k | €204k | €223k | €245k | €130k |
| Amounts payable within one year | 42/48 | €274k | €203k | €196k | €556k | €38k |
| Trade debts payable within one year | 44 | €3k | €3k | €4k | €481 | €885 |
| Income statement | ||||||
| Gross operating margin | 9900 | €449k | €414k | €424k | €362k | €293k |
| Operating result | 9901 | €419k | €380k | €389k | €332k | €276k |
| Financial income | 75 | €5k | €92 | €1 | - | €1 |
| Financial charges | 65 | €4k | €4k | €4k | €3k | €3k |
| Result before taxes | 9903 | €420k | €377k | €384k | €329k | €273k |
| Income taxes | 67/77 | €101k | €90k | €105k | €101k | €60k |
| Net result for the period | 9904 | €319k | €287k | €279k | €228k | €213k |
| Result to be appropriated | 9905 | €319k | €287k | €279k | €228k | €213k |
Legal Structure
| NACE primary | Specialist medical practice(86220) |
| Legal form | Private limited company(610) |
| Incorporation | 07-01-2019 |
| Status | Active |
| Postal code | 6280 |
Establishment units
Rue Napoléon Anrys(GER) 2, 6280 Gerpinnes
since 20192.283.464.825
Real-estate footprint
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52025C0234/00F000 | Wallonia | 1,656 m² | 1 · 172 m² | 11.0 m · 3 fl. |
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
Next filing, fiscal year 2026, expected by
2026
11-05
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2021net €319k ▲11.2%
Operating result €419k, net result €319k, both a record.
31-12
Financial
Equity above €500kEq €554k ▲11.8%
5 profitable years in a row build equity to €554k.
13-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
10-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
13-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
28-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
05-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 5 days late
2020
31-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Activities
Specialist medical practice86220Vocational training85592
Names & trade names
| Legal nameFR | VW MEDIC |
Similar companies
Schreurs - Huysmans
BE 0546.970.627 · Herentals
Dr Tina Vanderheyden
BE 0871.377.328 · Antwerpen
Dokter De Ceulaer, maxillofaciaal chirurg
BE 0507.624.160 · Sint-Martens-Latem
DOCTEUR SOPHIE HERENS BIOCLIN
BE 0792.495.344 · Liège
MDL Halet
BE 0647.921.990 · Essen